retatrutide mechanism gip glp-1 glucagon triple agonist Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data The Road towards Triple Agonists:

The study also reflects that those taking the medications for weight loss only are significantly more interested in products that offer key nutrients such as: Fortified with vitamins and nutrients (75%) High protein or protein fortified (74%) Gut health support (73%) For those no longer taking the medication, 76% report eating the same amount or less food

The glucagon component helps offset the metabolic decline associated with perimenopause and menopause

Metabolic healing happens internally before becoming visible externally

PMID: 40427605

What Makes Retatrutide More Effective Than Semaglutide in Research Models Retatrutides superior efficacy in body weight and metabolic parameter research, compared to semaglutide, is attributable to two additional receptor pathways